tiprankstipranks
StemGen Inc (SGNI)
OTHER OTC:SGNI
US Market

StemGen (SGNI) Income Statement

3 Followers

StemGen Income Statement

Last quarter (Q ), StemGen's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, StemGen's net income was $-185.77K. See StemGen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 21Jun 20Jun 19Jun 18Jun 17
Total Revenue
$ 20.00K$ 39.00K$ 19.35K$ 22.06K$ 0.00$ 0.00
Cost of Revenue
$ 12.04K$ 30.45K$ 8.57K$ 8.51K--
Gross Profit
$ 7.96K$ 8.55K$ 10.78K$ 13.55K--
Operating Expense
$ 408.20K$ 252.47K$ 77.85K$ 256.73K$ 32.33K$ 0.00
Operating Income
$ -400.24K$ -243.92K$ -67.07K$ -243.19K$ -32.33K$ 0.00
Net Non Operating Interest Income Expense
$ -140.80K$ -140.80K$ -140.80K$ -57.40K$ -91.57K$ -77.55K
Other Income Expense
$ 4.46K$ -48.42K$ -22.90K$ -124.92K$ 130.01K$ 7.55K
Pretax Income
$ -536.58K$ -433.14K$ -230.77K$ -425.51K$ 6.12K$ -70.00K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -536.58K$ -433.14K$ -230.77K$ -425.51K$ 6.12K$ -70.00K
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ <0.01$ >-0.01
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.02$ <0.01$ >-0.01
Basic Average Shares
$ 182.40M$ 45.60M$ 45.43M$ 24.45M$ 14.08M$ 14.08M
Diluted Average Shares
$ 182.40M$ 45.60M$ 45.43M$ 24.45M$ 14.08M$ 14.08M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 420.24K$ 282.92K$ 86.42K$ 265.24K$ 32.33K$ 0.00
Net Income From Continuing And Discontinued Operation
$ -536.58K$ -433.14K$ -230.77K$ -425.51K$ 6.12K$ -70.00K
Normalized Income
$ -541.04K$ -384.72K$ -207.87K$ -300.59K$ -88.79K$ -77.55K
Interest Expense
$ 140.80K$ 140.80K$ 140.80K$ 57.40K$ 91.57K$ 77.55K
EBIT
$ -395.78K$ -292.34K$ -89.97K$ -368.11K$ 97.69K$ 7.55K
EBITDA
$ -279.72K$ -179.87K$ -70.60K$ -308.11K$ 97.69K$ 7.55K
Currency in USD

StemGen Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis